Recall Radar
All recallsMedicine & devices

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharma…

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Class II Medicine & devices FDA July 8, 2026
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Boehringer Ingelheim Pharmaceuticals, Inc. — Ridgefield, CT
Severity
Class II — moderate
Reported
July 8, 2026
Quantity
560 bottles
Recall number
D-0657-2026
Status
Ongoing
Source
FDA

Where it went

OH

Other medicine & devices recalls

See every current recall on the live dashboard →